PubRank

Future science OA (Future Sci OA)

Journal PubWeight™ 112.59‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Development and therapeutic applications of nitric oxide releasing materials to treat erectile dysfunction. 2015 1.46
2 Looking to the future of organ-on-chip and toxicity assessment: a regulator's opinion. 2016 0.87
3 The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease. 2015 0.86
4 Alzheimer's disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset. 2016 0.85
5 Entering the 'big data' era in medicinal chemistry: molecular promiscuity analysis revisited. 2017 0.85
6 Welcome to volume 2 of Future Science OA. 2016 0.84
7 Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism. 2016 0.84
8 Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks. 2016 0.84
9 The effect of frailty should be considered in the management plan of older people with Type 2 diabetes. 2016 0.83
10 In search of an evidence-based role for psychiatry. 2016 0.82
11 A bioink by any other name: terms, concepts and constructions related to 3D bioprinting. 2016 0.82
12 Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. 2015 0.81
13 Analog series-based scaffolds: computational design and exploration of a new type of molecular scaffolds for medicinal chemistry. 2016 0.80
14 Harnessing the potentials of predictive microbiology in microbial food safety and quality research in Nigeria. 2016 0.79
15 Role of STAT3 pathway in genitourinary tumors. 2015 0.79
16 Obesity epidemic: impact from preconception to postpartum. 2016 0.78
17 How surgical care is changing in the technological era. 2016 0.78
18 Biomarkers for prostate cancer: present challenges and future opportunities. 2015 0.77
19 Quantitative analysis of lipids: a higher-throughput LC-MS/MS-based method and its comparison to ELISA. 2017 0.76
20 Clinical development of imatinib: an anticancer drug. 2016 0.76
21 The impact of blood shear rate on arterial thrombus formation. 2015 0.76
22 Detecting and monitoring NO, SNO and nitrite in vivo. 2016 0.76
23 The unfolded protein response in glioblastomas: targetable or trouble? 2015 0.76
24 Identification of Filamin-A and -B as potential biomarkers for prostate cancer. 2016 0.76
25 Organ-on-chip models: new opportunities for biomedical research. 2016 0.75
26 Electromagnetic fields in the treatment of chronic lower back pain in patients with degenerative disc disease. 2016 0.75
27 Tooth tissue engineering: tooth decellularization for natural scaffold. 2016 0.75
28 Features of endometrial cancer in patients with 'metabolically healthy' versus 'standard' obesity: the decreasing frequency of metabolically healthy obesity. 2015 0.75
29 Rhyme and reason: the role of circadian rhythms in skin and its implications for physicians. 2016 0.75
30 Opportunities in low-level radiocarbon microtracing: applications and new technology. 2015 0.75
31 Stories of experiences of care for growth hormone deficiency: the CRESCERE project. 2016 0.75
32 Normalized vitamin D metabolite concentrations are better correlated to pharmacological effects than measured concentrations. 2015 0.75
33 Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine. 2016 0.75
34 Should smoke exposure be considered an etiologic factor for cardiovascular disease? 2016 0.75
35 Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma. 2016 0.75
36 Making literature reviews more ethical: a researcher and health sciences librarian collaborative process. 2015 0.75
37 Supramolecular polymer formation by cyclic dinucleotides and intercalators affects dinucleotide enzymatic processing. 2016 0.75
38 Invertible micellar polymer nanoassemblies target bone tumor cells but not normal osteoblast cells. 2015 0.75
39 The likely role of proteolytic enzymes in unwanted differentiation of stem cells in culture. 2015 0.75
40 A Bridging Opportunities Work-frame to develop mobile applications for clinical decision making. 2015 0.75
41 NO supplementation for transfusion medicine and cardiovascular applications. 2016 0.75
42 Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management. 2015 0.75
43 Nanomedicine as a strategy to fight thrombotic diseases. 2015 0.75
44 Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report. 2015 0.75
45 Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood. 2015 0.75
46 Big data for big questions: it is time for data analysts to act. 2015 0.75
47 Averting the legacy of kidney disease: focus on childhood. 2016 0.75
48 Hyperglycemia during the immediate period following liver transplantation. 2016 0.75
49 Horizontal alignment of 5' -> 3' intergene distance segment tropy with respect to the gene as the conserved basis for DNA transcription. 2016 0.75
50 Lymphatic network in atherosclerosis: the underestimated path. 2015 0.75
Next 50